Clinical practice guidelines PSA testing & early management of test-detected prostate cancer


Clinical resources Clinical guidelines Guidelines by topic View all guidelines by topic Cancer Clinical practice guidelines PSA testing & early management of test-detected prostate cancer

What is in this guideline

Early management of test detected prostrate cancer
This guideline is intended for health professionals working with middle-aged and older men who do not have any symptoms that suggest they might have prostate cancer and are considering having a prostate-specific antigen (PSA) test, or who decide to have a test after they have been informed of the benefits and harms of testing.

It makes recommendations on how best to support men in making an informed decision for or against PSA testing and on which testing protocol to recommend to men who decide in favour of testing, depending on their age and underlying risk of prostate cancer. It also makes recommendations about further investigation after an abnormal PSA test result and the early management of prostate cancer diagnosed following such investigation.

The recommendations in this guideline are intended for people with training in medicine or other health sciences. They are not intended for the general public.



 

RACGP endorsed clinical guideline

This guideline is endorsed by the RACGP.
This guideline is published by the Cancer Council Australia